The Xstrata JV was entered into in 2010, long after AXT's share price was trashed. There was an initial blip in the shareprice but it went down over time. The market didnt really appreciate the enormity of the JV. Step in astute investors.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025